Ceftrex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ceftrex

Property Description
Active ingredient Ceftriaxone sodium
Form Sterile powder for solution
Pharmacological class Third-Generation Cephalosporin Antibiotic
General Purpose Treatment of bacterial infections
Origin Semisynthetic

Ceftrex is a specific trade name for a prescription-only medicine whose sole active compound is Ceftriaxone sodium. It is precisely categorized as a semisynthetic beta-lactam antimicrobial, placing it within the third generation of cephalosporin antibiotics. This advanced classification is clinically recognized for its superior stability and efficacy against a wide range of bacterial pathogens compared to earlier generations. Ceftriaxone is frequently utilized in scenarios requiring potent, broad-spectrum coverage, such as treating complicated community-acquired infections.

The medication is a single-entity product supplied as a sterile, dry powder for solution that contains only the active compound. This form is designed exclusively for parenteral administration, specifically via intramuscular (IM) or intravenous (IV) injection, following reconstitution with a sterile diluent. This injection-only format is a critical differentiating factor from many common oral antibiotics, guaranteeing that the high concentration required for treating systemic infections is rapidly achieved. Functionally, Ceftriaxone acts as a bactericidal agent, working by killing susceptible bacteria through the critical mechanism of halting the construction of their protective cell walls. This ensures the swift and reliable eradication of pathogens, which is the medicine's fundamental therapeutic purpose.

What side effects are possible with Ceftrex?

Ceftrex: Possible Side Effects and Safety Information

Ceftrex (ceftriaxone) is associated with both common and serious documented adverse reactions. Information is derived from regulatory labeling and post-marketing surveillance reports.


Common Adverse Reactions

The most frequently reported adverse reactions, occurring in over 2% of patients, generally involve the gastrointestinal and hematologic systems, and include: diarrhea, eosinophilia (elevated white blood cell count), thrombocytosis (elevated platelet count), leukopenia (low white blood cell count), and transient elevations of liver enzymes (SGOT/SGPT).

Serious and Clinically Significant Safety Concerns

The following are serious reactions documented in official regulatory sources:

  • Fatal Ceftriaxone-Calcium Precipitation: Precipitation in the lungs and kidneys, including fatal events, has been reported in neonates. Due to this risk, Ceftrex is contraindicated for simultaneous administration with calcium-containing intravenous solutions, including IV Ringer's or Hartmann's solutions, in all patient populations.
  • Hypersensitivity Reactions: Includes anaphylaxis (a severe, life-threatening allergic reaction) and serious skin reactions. Caution is advised for patients with a known history of penicillin allergy due to the risk of cross-hypersensitivity.
  • Clostridium difficile-associated Diarrhea (CDAD): This condition, which may range from mild diarrhea to fatal colitis, has been reported with nearly all antibacterial agents, including Ceftrex.
  • Hemolytic Anemia: Severe cases of hemolytic anemia, including fatalities in both adults and children, have been reported.
  • Neurological Adverse Reactions: Serious neurological effects such as convulsions, status epilepticus, and encephalopathy have been documented, particularly with high doses or in patients with both renal and hepatic impairment.

Population-Specific Safety Restrictions

Ceftrex is contraindicated in neonates (28 days of age or younger) with hyperbilirubinemia due to the theoretical risk of bilirubin encephalopathy. It is also contraindicated in this population if they require (or are expected to require) intravenous calcium-containing solutions due to the precipitation risk. For patients older than 28 days, Ceftrex and calcium-containing solutions may be administered sequentially if the infusion line is thoroughly flushed between infusions.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Ceftriaxone is primarily associated with an increased risk of specific, serious adverse events. Immediate medical attention must be sought in the event of a suspected overdose, even if no symptoms are apparent, as complications can be severe.

Documented Overdose Manifestations

The primary risks and manifestations of Ceftriaxone overdose involve the central nervous system (CNS) and the kidneys:

  • Neurological Disturbances: This can include disturbed consciousness, convulsions (seizures), involuntary movements, and in severe cases, encephalopathy.
  • Renal Complications: Overdose may increase the risk of urolithiasis (kidney stones) and subsequent post-renal acute renal failure.

Specific Overdose Considerations

Patients with severe renal impairment are at a particularly high risk for neurological toxicity due to reduced clearance of the drug, which can lead to higher serum concentrations. Monitoring for altered mental status or convulsions is critical in this population.

Emergency Actions

If overdose is suspected or if neurological symptoms like convulsions are observed, the administration of Ceftriaxone must be discontinued immediately.

Overdose treatment is typically symptomatic and supportive. Regulatory documents confirm that Ceftriaxone is not removed to any significant extent by hemodialysis or peritoneal dialysis, meaning these procedures are ineffective for reducing plasma drug concentration in an overdose scenario.

Therapeutic Uses of Ceftrex

Ceftrex (Ceftriaxone) is commonly used in clinical settings marked by increased physiological stress, playing a role in managing the infection, which is relevant for easing systemic symptoms when prompt, supportive symptom management is appropriate.


Key Therapeutic Domains and Patient Benefit

This medicine is generally applied in addressing conditions characterized by periods of heightened symptoms such as sepsis, bacterial meningitis, complicated forms of pneumonia, severe skin and soft tissue infections, and intra-abdominal infections. The medicine is considered relevant for easing symptoms that create noticeable physiological strain, such as persistent high fever, localized pain, and systemic distress. This may assist with maintaining functional stability during symptomatic phases.

The therapeutic application of this medication is consistent with use in situations involving certain distressing symptoms.

“It is commonly used when short-term symptomatic assistance is needed in clinical settings, such as high-risk hospital care or the perioperative period.”

Quick Fact: Relief for Systemic Discomfort

The use of Ceftrex helps address symptom clusters that may become intense or disruptive, and is relevant for managing symptoms that interfere with daily comfort during these phases.

Regulatory References

  1. DailyMed (FDA) Drug Label

Eligibility and Restrictions for Use

Who can and cannot use Ceftrex?

Ceftrex is a prescription antibiotic with specific regulatory limitations regarding who should or should not receive the medicine.

Contraindicated Populations (Must Not Use)

  • Individuals with a known allergy or hypersensitivity to ceftriaxone, any component of the formulation, or to any other cephalosporin class antibiotic.
  • Premature neonates up to a post-menstrual age of 41 weeks.
  • Hyperbilirubinemic neonates (jaundiced newborns) due to the risk of displacing bilirubin from albumin.
  • Neonates (le 28 days old) who are receiving or are expected to receive intravenous calcium-containing solutions, including continuous infusions like parenteral nutrition, due to the fatal risk of ceftriaxone-calcium precipitation in organs.

Special Considerations and Restrictions

  • Calcium Co-administration: In all patients, Ceftrex must not be administered simultaneously with calcium-containing intravenous solutions through the same infusion line. For patients older than 28 days, these two types of solutions may be administered sequentially if the IV line is thoroughly flushed between infusions.
  • Renal/Hepatic Impairment: Patients with significant impairment in both kidney and liver function should be monitored closely, and the daily dose may be limited to 2 g or less.
  • Age: Use in the elderly is permitted, as minimal changes in the drug's processing have been observed in this population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Ceftrex (Ceftriaxone) is defined primarily by its physical incompatibility and pharmacodynamic effects, as documented in official regulatory sources.

Calcium-Containing Solutions and IV Incompatibility

The most critical interaction is a formal prohibition against co-administration with intravenous (IV) solutions containing calcium, such as Lactated Ringer's solution or Parenteral Nutrition, due to the established risk of precipitate formation. This restriction applies to simultaneous administration in all patient age groups. For patients older than 28 days, Ceftriaxone and calcium products may be given sequentially, provided the intravenous line is thoroughly flushed with a compatible fluid between administrations.

Population-Specific and Other Drug Interactions

Use is formally contraindicated in neonates (28 days of age or younger) who require IV calcium products, even if sequential administration is planned. It is also contraindicated in hyperbilirubinemic neonates due to the risk of displacing bilirubin from serum albumin.

Co-administration with oral anticoagulants, such as Warfarin, may increase the potential for bleeding and formally alter prothrombin time. Furthermore, Ceftriaxone is physically incompatible with and must not be mixed with other IV agents including Vancomycin, Aminoglycosides, Amsacrine, and Fluconazole. The regulatory labels also note that the medicine may decrease the excretion rate of Acetaminophen and increase the excretion rate of Acetazolamide. Ceftriaxone does not pose the disulfiram-like reaction risk associated with alcohol consumption.

Mechanism of Action

Ceftrex’s mechanism of action is strictly bactericidal, centered on the irreversible disruption of the bacterial cell wall. The molecule functions as an irreversible inhibitor of essential bacterial enzymes called Penicillin-Binding Proteins (PBPs). These enzymes are transpeptidases necessary for constructing the rigid structure of the peptidoglycan layer. The beta-lactam core of Ceftriaxone mimics the PBP substrate and covalently acylates the enzyme's active site, neutralizing its function.

This PBP inactivation halts the final cross-linking step in cell wall biosynthesis. The incomplete cell wall cannot maintain the high internal pressure (turgor) characteristic of the bacterium, leading to a loss of osmotic integrity. The subsequent uncontrolled influx of water causes the cell to rupture, a process known as osmotic lysis. This targeted destruction is the physiological event that underlies the drug’s bactericidal effect. Efficacy is constrained by bacterial resistance mechanisms, including enzymatic hydrolysis by beta-lactamases or alterations to the PBP target structure.

Dosage and Administration Information

How to Use Ceftrex

Ceftrex, which contains ceftriaxone, is a medicine whose use is strictly governed by its official prescribing information and is typically administered in a professional healthcare setting due to its required route of administration.

Official Administration Guidelines

Instruction Category Official Rule/Instruction (Strictly Label-Based)
Route of Administration Must be administered parenterally via Intravenous (IV) injection/infusion or Intramuscular (IM) injection
Standard Dosing (Adults) A usual range of 1 g to 2 g is given once daily. The dose should not exceed 4 g per day, which is reserved for the most severe infections
Frequency and Duration Dosing is typically once daily (q24hr). Treatment generally continues for 4 to 14 days, based on clinical requirements

Procedural and Population-Specific Instructions

Because the medicine is supplied as a sterile powder, it requires reconstitution with a specific diluent immediately prior to use. Intravenous administration must be conducted slowly, typically over a minimum of 30 minutes for infusion.

There is a critical procedural restriction: Ceftriaxone solutions must not be mixed or co-administered with any calcium-containing IV solutions (e.g., Ringer's) due to the risk of precipitation. The maximum daily dose for patients with both severe hepatic and renal impairment is restricted to 2 g. If a dose is missed, it should be administered as soon as feasible, with the next dose given at the regularly scheduled time.

These official instructions define a rigorous, standardized protocol that dictates professional administration, precise preparation steps, and adherence to specific dosing limits based on the patient's condition and regulatory guidelines.

Recent Clinical Evidence

Ceftrex (ceftriaxone) is a third-generation cephalosporin antibiotic used to manage various bacterial infections. Recent clinical evidence, including data from randomized controlled trials and meta-analyses, continues to support its role in treating both community-acquired and hospital-acquired infections caused by susceptible organisms.

Efficacy Across Key Indications

Clinical data confirms the utility of ceftriaxone for several major indications, often related to its broad spectrum of activity against both Gram-positive and Gram-negative aerobic bacteria. Key areas of focus in recent research include:

  • Meningitis and Serious Infections: Studies confirm its ability to penetrate the cerebrospinal fluid (CSF), establishing its importance in the empiric and targeted treatment of bacterial meningitis and severe community-acquired pneumonia.
  • Surgical Prophylaxis: Systematic reviews have assessed ceftriaxone's effectiveness when administered prior to general surgical procedures, often showing favorable outcomes in reducing the rate of surgical site infections when compared to control groups.
  • Gonorrhea: Due to the emergence of resistant strains of Neisseria gonorrhoeae, ceftriaxone remains a core component of recommended combination therapy, with research continuously monitoring its sustained effectiveness against the shifting resistance patterns.

Ongoing Research and Resistance

Ongoing clinical investigations are exploring dosing strategies, particularly in patient populations like those with severe community-acquired pneumonia or methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs). For MSSA BSIs, research is evaluating if ceftriaxone can serve as an alternative to the standard of care, with some studies suggesting comparable clinical outcomes.

Despite its established efficacy, the increasing prevalence of beta-lactamase producing organisms and extended-spectrum beta-lactamases (ESBLs) requires continuous surveillance. Ceftriaxone retains a crucial position in the antimicrobial toolkit, but its continued effectiveness relies on careful microbiological sensitivity monitoring and appropriate use to manage the risk of antibiotic resistance.

Frequently Asked Questions (FAQ)

Common questions about Ceftrex (FAQ)


Q: Is Ceftrex used for any infections other than the main ones listed?

Yes, official regulatory documents list the medicine's use for a range of infections when caused by susceptible bacteria. These include infections of the bones and joints, skin and soft tissue infections, and complicated urinary tract infections, in addition to the major indications.


Q: Does Ceftrex interact with common pain relievers?

The official regulatory label notes that Ceftrex may affect the way the body handles certain common pain relievers. Specifically, official information notes a potential interaction with Acetaminophen, an ingredient found in many over-the-counter pain medications.


Q: What is the difference between Ceftrex and similar-sounding drugs?

Ceftrex contains the active compound Ceftriaxone, and it is formally categorized as a third-generation cephalosporin antibiotic. This classification places it within a specific class of antimicrobials that has distinct structural and activity properties compared to earlier and later generation drugs.


Q: Why do some people say Ceftrex is better than Amoxicillin?

Ceftrex is a third-generation cephalosporin, which is a newer class of antibiotic than Amoxicillin. Official information describes the third generation of cephalosporins, to which Ceftrex belongs, as having distinct structural and microbiological properties compared to earlier generations.


Q: Are there any known issues combining Ceftrex with cold or flu medicine?

Official information notes that this medicine may decrease the excretion rate of Acetaminophen, an ingredient commonly found in cold and flu preparations. The regulatory label notes a potential interaction with Acetaminophen, which may be an ingredient in certain cold and flu preparations.


Q: Can Ceftrex cause changes in mood or behavior?

Official documentation lists neurological adverse reactions associated with this medicine. These effects may include less common effects such as confusion and hallucinations, in addition to serious but rare effects like convulsions, as noted in the official prescribing information.


Q: Why are the instructions different for different people using Ceftrex?

The prescribed dose, as outlined in official tables, is adjusted based on the individual patient’s needs. These needs may include the nature and severity of the infection and the patient's specific health status.


Q: Is it true that Ceftrex can make you feel tired?

Tiredness (or fatigue) is listed among the less common side effects documented in the official regulatory information for this medicine.


Q: Can Ceftrex affect birth control pills?

Official information notes that this antibiotic may reduce the effects of estradiol, a hormone found in some oral contraceptives (birth control pills). This interaction may increase the potential for pregnancy or cause breakthrough bleeding.


Q: Are there any foods or drinks to avoid while using Ceftrex?

The most critical restriction noted in the official label is the formal prohibition against mixing this medicine with or simultaneously administering it with calcium-containing IV solutions. Dairy products in the diet are generally not addressed by this specific prohibition.


Q: How long does Ceftrex stay in your system after the last use?

Official pharmacokinetic studies indicate that the medicine has an elimination half-life that typically ranges from 5.8 to 8.7 hours in human subjects.


Q: Is it normal to have a slight headache after starting Ceftrex?

Headache is listed in the official documents as an uncommon side effect.


Q: Does Ceftrex affect blood pressure?

Some regulatory reports indicate that blood pressure can decrease during the infusion of the medicine. The administration protocol specifies that the medicine should be infused slowly.


Q: What does the official drug label say about using Ceftrex and driving?

Official prescribing information notes that side effects such as dizziness or headache may occur. These types of effects may potentially impact the ability to drive or operate machinery.


Q: What if I take Ceftrex with dairy products?

The critical restriction is the formal prohibition against mixing it with or simultaneously administering it with calcium-containing IV solutions. Dairy products consumed as part of the diet are generally not addressed in this formal prohibition.


Q: Why is Ceftrex sometimes given in a hospital setting?

The medicine is strictly formulated for intravenous (IV) or intramuscular (IM) injection and requires a professional healthcare setting for preparation and administration. Furthermore, its approved uses include treating severe infections which often require hospitalization.


Q: Is Ceftrex used to treat fungal or viral infections?

No. The medicine is an antibacterial drug and is indicated only for infections proven or strongly suspected to be caused by bacteria. It is not indicated for the treatment of viral infections (like the common cold) or fungal infections.


Q: Does Ceftrex lose effectiveness over time?

Official documents caution that the medicine should be used only for proven or suspected bacterial infections to help manage the risk of drug-resistant bacteria and support the medicine's continued effectiveness.


Q: What if a user has a rare or serious side effect?

Official regulatory documents list serious adverse reactions (e.g., severe allergic reaction, convulsions) and note that immediate medical attention is necessary if a serious or severe reaction is observed.


Q: Is Ceftrex safe to use during pregnancy?

The U.S. Food and Drug Administration (FDA) previously classified the medicine as a Pregnancy Category B drug. This classification indicates that animal reproduction studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.


How should Ceftrex be stored and disposed of?

Storage and Disposal of Ceftrex (Ceftriaxone Sodium)

Ceftrex, supplied as a sterile powder for injection, requires specific storage and handling to maintain its potency.


️ Storage Conditions

Preparation State Temperature Requirement Stability Constraint
Unreconstituted Powder Controlled Room Temperature (20°C to 25°C / 68°F to 77°F) Protect from light
Reconstituted Solution Refrigerated (2°C to 8°C / 36°F to 46°F) Use within 24 hours

The powder must be kept in its original container and stored out of the sight and reach of children.


️ Disposal Requirements

Any unused medicinal product or waste material must be discarded in accordance with local requirements. The medicine should not be disposed of via household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ceftrex found in:

A-Z Index: